Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P. H. Chandrasekar

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Infection|September 1, 1985
Clinical features and antimicrobial therapy of infections caused by group G streptococciK V Rolston, P H Chandrasekar, J L LeFrock
Pharmacotherapy|January 1, 1987
Spiramycin in the treatment of cryptosporidiosisA M Pilla, M J Rybak, P H Chandrasekar
Antimicrobial Agents and Chemotherapy|September 1, 1993
Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic miceP H Chandrasekar, J A Sluchak, J A Kruse
Southern Medical Journal|September 1, 1990
Risk factors for human immunodeficiency virus infection among parenteral drug abusers in a low-prevalence areaP H Chandrasekar, J A Molinari, J A Kruse
Antimicrobial Agents and Chemotherapy|October 31, 1998
Organism-dependent fungicidal activities of azolesE K Manavathu, J L Cutright, P H Chandrasekar
The Journal of Antimicrobial Chemotherapy|April 1, 1984
Antimicrobial tolerance in group C and group G streptococciK V Rolston, P H Chandrasekar, J L LeFrock
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999P H Chandrasekar, J L Cutright, E K Manavathu
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2001
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatusE K Manavathu, O C Abraham, P H Chandrasekar
Bone Marrow Transplantation|August 23, 2005
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)J I Ito, P H Chandrasekar, R Hooshmand-Rad
The Journal of Antimicrobial Chemotherapy|August 1, 1998
In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatusE K Manavathu, G J Alangaden, P H Chandrasekar
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Infection|September 1, 1985
Clinical features and antimicrobial therapy of infections caused by group G streptococciK V Rolston, P H Chandrasekar, J L LeFrock
Pharmacotherapy|January 1, 1987
Spiramycin in the treatment of cryptosporidiosisA M Pilla, M J Rybak, P H Chandrasekar
Antimicrobial Agents and Chemotherapy|September 1, 1993
Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic miceP H Chandrasekar, J A Sluchak, J A Kruse
Southern Medical Journal|September 1, 1990
Risk factors for human immunodeficiency virus infection among parenteral drug abusers in a low-prevalence areaP H Chandrasekar, J A Molinari, J A Kruse
Antimicrobial Agents and Chemotherapy|October 31, 1998
Organism-dependent fungicidal activities of azolesE K Manavathu, J L Cutright, P H Chandrasekar
The Journal of Antimicrobial Chemotherapy|April 1, 1984
Antimicrobial tolerance in group C and group G streptococciK V Rolston, P H Chandrasekar, J L LeFrock
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999P H Chandrasekar, J L Cutright, E K Manavathu
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2001
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatusE K Manavathu, O C Abraham, P H Chandrasekar
Bone Marrow Transplantation|August 23, 2005
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)J I Ito, P H Chandrasekar, R Hooshmand-Rad
The Journal of Antimicrobial Chemotherapy|August 1, 1998
In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatusE K Manavathu, G J Alangaden, P H Chandrasekar
Pageof 8